---
title: "PMGC Holdings Inc. (ELAB.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ELAB.US.md"
symbol: "ELAB.US"
name: "PMGC Holdings Inc."
industry: "Personal Care Products"
datetime: "2026-05-21T13:43:19.452Z"
locales:
  - [en](https://longbridge.com/en/quote/ELAB.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ELAB.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ELAB.US.md)
---

# PMGC Holdings Inc. (ELAB.US)

## Company Overview

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company’s lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and production of high-tolerance components for industrial and technological applications.

| Item | Detail |
|------|--------|
| Industry | Personal Care Products |
| Exchange | US Market |
| Website | [mgcholdings.com](https://mgcholdings.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:16.000Z

**Overall: D (0.67)**

**Industry**: Personal Care Products

| Metric | Value |
|--------|-------|
| Industry Ranking | 50 / 56 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 0.00% |  |
| Net Profit YoY | -72.01% |  |
| P/B Ratio | 0.27 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3369981.54 |  |
| Revenue | 1272078.00 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -107.91% | E |
| Profit Margin | -873.11% | E |
| Gross Margin | 33.59% | C |
| Revenue YoY | 0.00% | D |
| Net Profit YoY | -72.01% | E |
| Total Assets YoY | 192.88% | A |
| Net Assets YoY | 55.09% | A |
| Cash Flow Margin | 68.12% | C |
| OCF YoY | 0.00% | D |
| Turnover | 0.07 | E |
| Gearing Ratio | 51.58% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - PMGC Holdings Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "0.00%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-72.01%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.27",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "3369981.54",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "1272078.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-107.91%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-873.11%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "33.59%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "0.00%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-72.01%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "192.88%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "55.09%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "68.12%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "0.00%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.07",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "51.58%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.30 | 25/56 | - | - | - |
| PB | 0.27 | 4/56 | 0.46 | 0.36 | 0.24 |
| PS (TTM) | 2.65 | 37/56 | 10.23 | 6.76 | 4.16 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | L'Oréal S.A. (LRLCY.US) | A | B | B | C | B | B |
| 02 | Beiersdorf (BDRFY.US) | B | B | B | B | C | B |
| 03 | Kao Corporation (KAOOY.US) | B | C | A | B | C | B |
| 04 | ELF Beauty (ELF.US) | B | B | B | C | B | B |
| 05 | Interparfums (IPAR.US) | A | C | A | B | C | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/ELAB.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/ELAB.US/norm.md)
- [Related News](https://longbridge.com/en/quote/ELAB.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/ELAB.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**